作者
Ali Rezaie, M Ellen Kuenzig, Eric I Benchimol, Anne Marie Griffiths, Anthony R Otley, A Hillary Steinhart, Gilaad G Kaplan, Cynthia H Seow
发表日期
2015
来源
Cochrane Database of Systematic Reviews
期号
6
出版商
John Wiley & Sons, Ltd
简介
Background
Corticosteroids are commonly used for the induction of remission in Crohn's disease. However, traditional corticosteroids can cause significant adverse events. Budesonide is an alternative glucocorticoid with limited systemic bioavailability.
Objectives
The primary objective was to evaluate the efficacy and safety of oral budesonide for the induction of remission in Crohn's disease.
学术搜索中的文章
A Rezaie, ME Kuenzig, EI Benchimol, AM Griffiths… - Cochrane Database of Systematic Reviews, 2015